These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

209 related articles for article (PubMed ID: 30425004)

  • 1. miRNA arm switching identifies novel tumour biomarkers.
    Chen L; Sun H; Wang C; Yang Y; Zhang M; Wong G
    EBioMedicine; 2018 Dec; 38():37-46. PubMed ID: 30425004
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Combined identification of three miRNAs in serum as effective diagnostic biomarkers for HNSCC.
    Liu C; Yu Z; Huang S; Zhao Q; Sun Z; Fletcher C; Jiang Y; Zhang D
    EBioMedicine; 2019 Dec; 50():135-143. PubMed ID: 31780396
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The beagle dog MicroRNA tissue atlas: identifying translatable biomarkers of organ toxicity.
    Koenig EM; Fisher C; Bernard H; Wolenski FS; Gerrein J; Carsillo M; Gallacher M; Tse A; Peters R; Smith A; Meehan A; Tirrell S; Kirby P
    BMC Genomics; 2016 Aug; 17():649. PubMed ID: 27535741
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A novel microRNA signature predicts survival in stomach adenocarcinoma.
    Ding B; Gao X; Li H; Liu L; Hao X
    Oncotarget; 2017 Apr; 8(17):28144-28153. PubMed ID: 28423653
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Next generation sequencing profiling identifies miR-574-3p and miR-660-5p as potential novel prognostic markers for breast cancer.
    Krishnan P; Ghosh S; Wang B; Li D; Narasimhan A; Berendt R; Graham K; Mackey JR; Kovalchuk O; Damaraju S
    BMC Genomics; 2015 Sep; 16():735. PubMed ID: 26416693
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Statistical Methods for Identifying Biomarkers from miRNA Profiles of Cancers.
    Namkung J
    Methods Mol Biol; 2019; 1882():261-286. PubMed ID: 30378062
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Hepatocellular carcinoma associated microRNA expression signature: integrated bioinformatics analysis, experimental validation and clinical significance.
    Shi KQ; Lin Z; Chen XJ; Song M; Wang YQ; Cai YJ; Yang NB; Zheng MH; Dong JZ; Zhang L; Chen YP
    Oncotarget; 2015 Sep; 6(28):25093-108. PubMed ID: 26231037
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A Cluster-Based Approach for Identifying Prognostic microRNA Signatures in Digestive System Cancers.
    Zhou J; Cui X; Xiao F; Cai G
    Int J Mol Sci; 2021 Feb; 22(4):. PubMed ID: 33546390
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Identifying a miRNA signature for predicting the stage of breast cancer.
    Yerukala Sathipati S; Ho SY
    Sci Rep; 2018 Oct; 8(1):16138. PubMed ID: 30382159
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Key miRNAs and target genes played roles in the development of clear cell renal cell carcinoma.
    Liu J; Liu B; Guo Y; Chen Z; Sun W; Gao W; Wu H; Wang Y
    Cancer Biomark; 2018; 23(2):279-290. PubMed ID: 30198869
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pan-cancer analysis on microRNA-associated gene activation.
    Tan H; Huang S; Zhang Z; Qian X; Sun P; Zhou X
    EBioMedicine; 2019 May; 43():82-97. PubMed ID: 30956173
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Genome-wide analysis of multi-view data of miRNA-seq to identify miRNA biomarkers for stomach cancer.
    Pant N; Rakshit S; Paul S; Saha I
    J Biomed Inform; 2019 Sep; 97():103254. PubMed ID: 31352060
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Dual strands of the miR-223 duplex (miR-223-5p and miR-223-3p) inhibit cancer cell aggressiveness: targeted genes are involved in bladder cancer pathogenesis.
    Sugawara S; Yamada Y; Arai T; Okato A; Idichi T; Kato M; Koshizuka K; Ichikawa T; Seki N
    J Hum Genet; 2018 May; 63(5):657-668. PubMed ID: 29540855
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Three-microRNA signature identified by bioinformatics analysis predicts prognosis of gastric cancer patients.
    Zhang C; Zhang CD; Ma MH; Dai DQ
    World J Gastroenterol; 2018 Mar; 24(11):1206-1215. PubMed ID: 29568201
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Plasma miRNAs in diagnosis and prognosis of pancreatic cancer: A miRNA expression analysis.
    Zhou X; Lu Z; Wang T; Huang Z; Zhu W; Miao Y
    Gene; 2018 Oct; 673():181-193. PubMed ID: 29913239
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Dissecting the biological relationship between TCGA miRNA and mRNA sequencing data using MMiRNA-Viewer.
    Bai Y; Ding L; Baker S; Bai JM; Rath E; Jiang F; Wu J; Jiang H; Stuart G
    BMC Bioinformatics; 2016 Oct; 17(Suppl 13):336. PubMed ID: 27766936
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A novel microRNAs expression signature for hepatocellular carcinoma diagnosis and prognosis.
    Lu M; Kong X; Wang H; Huang G; Ye C; He Z
    Oncotarget; 2017 Jan; 8(5):8775-8784. PubMed ID: 28060739
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Analysis of miRNA expression profiles in breast cancer using biclustering.
    Fiannaca A; La Rosa M; La Paglia L; Rizzo R; Urso A
    BMC Bioinformatics; 2015; 16 Suppl 4(Suppl 4):S7. PubMed ID: 25734576
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Visual Display of 5p-arm and 3p-arm miRNA Expression with a Mobile Application.
    Pan CY; Kuo WT; Chiu CY; Lin WC
    Biomed Res Int; 2017; 2017():6037168. PubMed ID: 28271066
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Identifying the miRNA signature associated with survival time in patients with lung adenocarcinoma using miRNA expression profiles.
    Yerukala Sathipati S; Ho SY
    Sci Rep; 2017 Aug; 7(1):7507. PubMed ID: 28790336
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.